Vectors Research Management’s Colgate-Palmolive CL Stock Holding History

Vectors Research Management’s Portfolio CL Stock Details CL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-1,184	Closed	-$101K	–	486
2021 Q4	$101K	Buy	1,184 +6	+0.5%	+$469	0.02%	206
2021 Q3	$89K	Buy	1,178 +7	+0.6%	+$556	0.02%	203
2021 Q2	$95K	Buy	+1,171	New	+$95.7K	0.02%	195
2020 Q3	–	Sell	-135	Closed	-$10K	–	431
2020 Q2	$10K	Hold	135	–	–	﹤0.01%	296
2020 Q1	$9K	Hold	135	–	–	﹤0.01%	303
2019 Q4	$9K	Buy	+135	New	+$9.2K	﹤0.01%	358
2019 Q1	–	Sell	-133	Closed	-$8K	–	432
2018 Q4	$8K	Hold	133	–	–	﹤0.01%	476
2018 Q3	$9K	Buy	+133	New	+$8.86K	0.01%	328

Other funds holding CL

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

First Eagle Investment Management New York $59B AUM 32.99% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Vectors Research Management's CL Position: Q1 2022 in Review

Vectors Research Management sold out of Colgate-Palmolive (CL) in Q1 2022, closing a stake of 1,184 shares — an estimated $101K sold.

Vectors Research Management first reported a position in CL in Q3 2018 and held it in 8 quarters. The position peaked at $101K in Q4 2021. 1,632 funds tracked by Wall St. Rank hold CL as of Q1 2022.

Vectors Research Management reported no remaining Colgate-Palmolive position as of Q1 2022 after selling out during the quarter.
Vectors Research Management sold 1,184 Colgate-Palmolive shares in Q1 2022, an estimated $101K.
Vectors Research Management first reported a position in Colgate-Palmolive in Q3 2018 and held it in 8 quarters.
Vectors Research Management's Colgate-Palmolive position peaked at $101K in Q4 2021.
1,632 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q1 2022.

Based on Vectors Research Management's 13F filing for Q1 2022, filed 16 May 2022.